Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030 is a research paper published in Annals of Oncology (2023). On theSindex it has a DataRank of 1.7. It has been cited 58 times, with 46 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.612
From this paper's citation signal
Citation Network Contribution
1.1
From 36 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 46 citers.
National Institutes of Health
Grant: R01 CA221874
National Cancer Institute
Grant: 1K08CA252639
NCI NIH HHS
Grant: K08 CA252639
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 1K08CA252639-01A1
Can a subset of patients with HER2+ metastatic breast cancer be cured?
National Institutes of Health
Grant: 2R01CA221874-04
Comprehensive minimal residual disease tracking in cancer
Breast Cancer Research Foundation
National Cancer Institute
National Institutes of Health
Susan G. Komen
Gerstner Family Foundation
FWCI
6.70
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals